Xenotransplantation elicits salient tumorigenicity of adult T-cell leukemia-derived cells via aberrant AKT activation
- Cancer Sci. 2016 May;107(5):638-43. doi: 10.1111/cas.12921.
- 1. Division of Molecular and Cellular Oncology, Miyagi Cancer Center Research Institute, Natori, Japan.
- 2. Department of Cancer Science, Tohoku University Graduate School of Medicine, Sendai, Japan.
- 3. Department of Hematology and Rheumatology, Tohoku University Graduate School of Medicine, Sendai, Japan.
- 4. Division of Cancer Biology and Therapeutics, Miyagi Cancer Center Research Institute, Natori, Japan.
- 5. Department of Pathology, Miyagi Cancer Center, Natori, Japan.
- 6. Division of Hematology, Miyagi Cancer Center, Natori, Japan.
- 7. Division of Cancer Stem Cells, Miyagi Cancer Center Research Institute, Natori, Japan.
The transplantation of human Cancer cells into immunodeficient NOD/SCID/IL-2Rγc(null) (NOG) mice often causes highly malignant cell populations like Cancer Stem Cells to emerge. Here, by serial transplantation in NOG mice, we established two highly tumorigenic adult T-cell leukemia-derived cell lines, ST1-N6 and TL-Om1-N8. When transplanted s.c., these cells formed tumors significantly earlier and from fewer initial cells than their parental lines ST1 and TL-Om1. We found that protein kinase B (Akt) signaling was upregulated in ST1-N6 and TL-Om1-N8 cells, and that this upregulation was due to the decreased expression of a negative regulator, INPP5D. Furthermore, the introduction of a constitutively active Akt mutant expression vector into ST1 cells augmented the tumorigenicity of the cells, whereas treatment with the Akt Inhibitor MK-2206 attenuated the progression of tumors induced by ST1-N6 cells. Collectively, our results reveal that the Akt signaling pathway plays a critical role in the malignancy of adult T-cell leukemia-derived cells.
-
Cat. No.Product NameDescriptionTargetResearch Area
-
target: Biochemical Assay ReagentsResearch Areas: Others